These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37279045)

  • 1. Ginsenosides can target brain-derived neurotrophic factor to improve Parkinson's disease.
    Ding Y; Botchway BOA; Zhang Y; Liu X
    Food Funct; 2023 Jun; 14(12):5537-5550. PubMed ID: 37279045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson's disease.
    Kang SS; Zhang Z; Liu X; Manfredsson FP; Benskey MJ; Cao X; Xu J; Sun YE; Ye K
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10773-10778. PubMed ID: 28923922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy.
    Ali NH; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; AlAseeri AA; Alruwaili M; Saad HM; Batiha GE
    J Cell Mol Med; 2024 May; 28(10):e18368. PubMed ID: 38752280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BDNF-TrkB signaling pathway is partially involved in the neuroprotective effects of hydrogen sulfide in Parkinson's disease.
    Hacioglu G; Cirrik S; Tezcan Yavuz B; Tomruk C; Keskin A; Uzunoglu E; Takir S
    Eur J Pharmacol; 2023 Apr; 944():175595. PubMed ID: 36804547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson's disease rats through neuroprotection and anti-neuroinflammation.
    Jiang Z; Wang J; Sun G; Feng M
    Mol Cell Neurosci; 2022 Dec; 123():103784. PubMed ID: 36228967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
    Sampaio TB; Pinton S; da Rocha JT; Gai BM; Nogueira CW
    Eur J Pharmacol; 2017 Jan; 795():28-35. PubMed ID: 27915043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive Rehabilitation Enhances Lymphocyte BDNF-TrkB Signaling in Patients With Parkinson's Disease.
    Fontanesi C; Kvint S; Frazzitta G; Bera R; Ferrazzoli D; Di Rocco A; Rebholz H; Friedman E; Pezzoli G; Quartarone A; Wang HY; Ghilardi MF
    Neurorehabil Neural Repair; 2016 Jun; 30(5):411-8. PubMed ID: 26253177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin can improve Parkinson's disease via activating BDNF/PI3k/Akt signaling pathways.
    Jin T; Zhang Y; Botchway BOA; Zhang J; Fan R; Zhang Y; Liu X
    Food Chem Toxicol; 2022 Jun; 164():113091. PubMed ID: 35526734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.
    Berghauzen-Maciejewska K; Wardas J; Kosmowska B; Głowacka U; Kuter K; Ossowska K
    PLoS One; 2015; 10(3):e0117698. PubMed ID: 25739024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells.
    Novosadova EV; Nenasheva VV; Makarova IV; Dolotov OV; Inozemtseva LS; Arsenyeva EL; Chernyshenko SV; Sultanov RI; Illarioshkin SN; Grivennikov IA; Tarantul VZ
    J Mol Neurosci; 2020 Apr; 70(4):514-521. PubMed ID: 31820346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF as a Promising Therapeutic Agent in Parkinson's Disease.
    Palasz E; Wysocka A; Gasiorowska A; Chalimoniuk M; Niewiadomski W; Niewiadomska G
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinson's and Alzheimer's Diseases.
    Mohammadi A; Amooeian VG; Rashidi E
    Curr Gene Ther; 2018; 18(1):45-63. PubMed ID: 29512462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional modification of recombinant brain-derived neurotrophic factor and its protective effect against neurotoxicity.
    Liu C; Yan Q; Ding X; Zhao M; Chen C; Zheng Q; Yang H; Xie Y
    Int J Biol Macromol; 2024 May; 267(Pt 2):131610. PubMed ID: 38621565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents.
    Massa SM; Yang T; Xie Y; Shi J; Bilgen M; Joyce JN; Nehama D; Rajadas J; Longo FM
    J Clin Invest; 2010 May; 120(5):1774-85. PubMed ID: 20407211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian control of BDNF-mediated Nrf2 activation in astrocytes protects dopaminergic neurons from ferroptosis.
    Ishii T; Warabi E; Mann GE
    Free Radic Biol Med; 2019 Mar; 133():169-178. PubMed ID: 30189266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra.
    von Bohlen und Halbach O; Minichiello L; Unsicker K
    FASEB J; 2005 Oct; 19(12):1740-2. PubMed ID: 16037097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach.
    Zarneshan SN; Fakhri S; Khan H
    Pharmacol Res; 2022 Mar; 177():106099. PubMed ID: 35092819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson's disease.
    Tuon T; Valvassori SS; Dal Pont GC; Paganini CS; Pozzi BG; Luciano TF; Souza PS; Quevedo J; Souza CT; Pinho RA
    Brain Res Bull; 2014 Sep; 108():106-12. PubMed ID: 25264157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baicalein alleviates depression-like behavior in rotenone- induced Parkinson's disease model in mice through activating the BDNF/TrkB/CREB pathway.
    Zhao X; Kong D; Zhou Q; Wei G; Song J; Liang Y; Du G
    Biomed Pharmacother; 2021 Aug; 140():111556. PubMed ID: 34087694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rb1 pretreatment reverses hippocampal changes in BDNF/TrkB mRNA and protein in rats subjected to acute immobilization stress.
    Kang X; Hong W; Xie K; Tang H; Tang J; Luo S; Geng W; Jia D
    Drug Des Devel Ther; 2019; 13():2127-2134. PubMed ID: 31308626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.